Susan Stocker
, United States
344196 RESULTS
, United States
Icahn School of Medicine at Mount SinaiUnited States
CONFERENCE 2025-10-01 00:00:00-2025-10-04 00:00:00 St. Julians, Malta 01 – 04 October 2025 View Conference Website 0
CONFERENCE 2025-12-01 00:00:00-2025-12-04 00:00:00 San Diego, California 01 – 04 December 2025 View Conference Website 0
CONFERENCE 2025-10-04 00:00:00-2025-10-07 00:00:00 St. Julians, Malta 04 – 07 October 2025 View Conference Website 0
COMMENT Yes, we agree with these critiques. In fact, when Nature Genetics accepted the proxy “AD” GWAS paper, we wrote saying it had been poorly reviewed (Bellenguez et al., 2022). A better title for the original paper would have been “A Proxy GWAS for Reported D
CONFERENCE 2025-03-25 00:00:00-2025-03-25 00:00:00 London, U.K. 25 March 2025 View Conference Website 0
CONFERENCE 2025-06-06 00:00:00-2025-06-11 00:00:00 Newry, Maine 06 – 11 June 2025 View Conference Website 0
COMMENT Genome-wide association studies on Alzheimer’s disease and related dementias mainly focus on the identification of new genetic risk factors for ADRD. Performing a GWAX, i.e., a GWAS on proxy ADRD cases (i.e. individuals reporting at least one parent with
CONFERENCE 2025-06-01 00:00:00-2025-06-06 00:00:00 Newport, Rhode Island 01 – 06 June 2025 View Conference Website 0
University of Texas Medical BranchUnited States
CONFERENCE 2025-03-02 00:00:00-2025-03-07 00:00:00 Pomona, California 02 – 07 March 2025 View Conference Website 0
CONFERENCE 2025-06-08 00:00:00-2025-06-13 00:00:00 Manchester, New Hampshire 08 – 13 June 2025 View Conference Website 0
COMMENT This study reports associations between apraxia symptoms and tau PET signal in a sample of 34 individuals with a clinical diagnosis of Alzheimer’s disease and biomarker evidence of AD neuropathologic change. The study is a clear example of brain mapping w
Nautilus BiotechnologyUnited States
No filters selected